作者回复:在IgA脏病中使用Ravulizumab:向疾病修改迈出的有希望的步骤?
Jonathan Barratt1, Youssef M K Farag2, Min Yee3
1Mayer IgA Nephropathy Laboratories, Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom.
No abstract available in PubMed .
更多相关视频
14:18Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
09:43Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
相关概念视频
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome III : Nursing Management
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Rheumatic Heart Disease III: Medical Management
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
